-
Mok Talk | Lung Cancer Leadership, Innovation, and the Power of Collaboration
In this special episode of Mok Talk, Professor Tony Mok (The Chinese University of Hong Kong) sits down with three rising oncology experts Professor Yang Xia (Zhejiang University), Professor Wenhua…
-
Temocillin in the Spotlight: Dr. Francesco Cogliati Dezza on Tackling Antimicrobial Resistance
At ESCMID Global 2025, Infectious Disease Frontier sat down with Dr. Francesco Cogliati Dezza to discuss the renewed clinical relevance of temocillin. As resistance to broad-spectrum antibiotics continues to rise,…
-
Advancing the Diagnosis and Prevention of Congenital CMV: Insights from Dr. Marianne Leruez-Ville
Dr. Marianne Leruez-Ville, a prominent clinical virologist, shared her insights into improving diagnostic tools, the promise of vaccines and antivirals, and how a multidisciplinary approach is key to optimizing outcomes…
-
Temocillin and the Search for Carbapenem Alternatives: A Conversation with Dr. Francesco Cogliati Dezza at ESCMID Global 2025
IDF: The issue of carbapenem resistance is becoming increasingly severe, while drugs like Temocillin seem to be overlooked. What do you think is the significance of seeking carbapenem alternative solutions?…
-
Prof. Lin Visits MGH | Talk with Prof. Lori Wirth on Targeted Therapy for Advanced Thyroid Cancer
Join us for an exclusive conversation between Prof. Yansong Lin of Peking Union Medical College Hospital and Prof. Lori Wirth at Massachusetts General Hospital. In this special academic exchange, the…
-
Redefining Standards in Urothelial Cancer: A Conversation with Dr. Thomas Powles
In this exclusive UroStream interview, we had the privilege of speaking with Dr. Thomas Powles, MD, a leading oncologist at Barts Health NHS Trust and the global lead investigator of…
-
“50 Years of Hematopoietic Stem Cell Transplantation”
We were honored to hear from Professor Xiaojun Huang of Peking University People’s Hospital and the Peking University Institute of Hematology, who shared a comprehensive reflection on the global evolution of hematopoietic stem cell transplantation (HSCT). From Dr. Edward Donnall Thomas’ foundational work to the creation of the Beijing Protocol, Professor Huang spotlighted how China’s…
-
CSCO Guidelines Conference | Academician Jinming Yu: From the “Jinan Miracle” in Radiation Therapy to Advancing Immunotherapy and International Collaboration
The 2025 CSCO Guidelines Conference, co-hosted by the Chinese Society of Clinical Oncology (CSCO) and the Beijing Xisike Clinical Oncology Research Foundation, was successfully held in Jinan, April 18–19, 2025. Leading experts from across the country gathered once again to exchange cutting-edge research, discuss clinical hot topics, and witness the release of updated CSCO guidelines.…
Connecting Medical Expertise through Media